The basal-bolus insulin regimen is the starting treatment for individuals with type 1 (DM1) diabetes, whereas in patients with diabetes type 2 (DM2), it is the final step when an optimal glycemic control is not obtained with other antidiabetic drugs (OADs), or these are contraindicated. The gene discussed is INS; the disease is diabetes mellitus.